Theriva™ Biologics anuncia varias presentaciones en congresos médicos 05/11/2025 Access to innovation VCN-01 expanded mPDAC data from VIRAGE Phase 2b trial to be presented at ESMO 2025 Partners - THERIVA BIOLOGICS S.L.
GENESIS Biomed participated in the strategic development of AptaTargets, which has license... 30/10/2025 Access to innovation Financing AptaTargets signed in May 2025 a licensing agreement with Merck for the clinical development and global... Partners - GENESIS Biomed
19TH ANNUAL EUROPEAN LIFE SCIENCES CEO FORUM FOR PARTNERING & INVESTMENT Zurich Switzerland Del 04/03/2026 to 05/03/2026 Access to innovation
1ST ANNUAL EUROPEAN NEUROSCIENCE INNOVATION FORUM FOR BUSINESS DEVELOPMENT, LICENSING & IN... Zurich Switzerland Del 03/03/2026 to 03/03/2026 Access to innovation
EUCROF26 (European Clinical Research Conference) Amsterdam The Netherlands Del 02/02/2026 to 04/02/2026 Access to innovation
